Safety and Feasibility of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy With Calcium‐Containing Solutions: A Randomized Controlled Trial
Seminars in Dialysis · 2024
DOI: 10.1111/sdi.13200 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Seminars in Dialysis, 2024. Verfasst von Shan Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China. Hauptthemen laut MEDLINE: Continuous Renal Replacement Therapy, Anticoagulants, Feasibility Studies, Citric Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xiamen Science and Technology Project, Science and Technology Projects of Fujian Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Calcium‐free (Ca‐free) solutions are theoretically the most ideal for regional citrate anticoagulation (RCA) in continuous renal replacement therapy (CRRT). However, the majority of medical centers in China had to make a compromise of using commercially available calcium‐containing (Ca‐containing) solutions instead of Ca‐free ones due to their scarcity. This study was designed to probe into the potential of Ca‐containing solution as a secure and efficient substitution for Ca‐free solutions.
Methods
In this prospective, randomized single‐center trial, 99 patients scheduled for CRRT were randomly assigned in a 1:1:1 ratio to one of three treatment groups: continuous veno‐venous hemodialysis Ca‐free dialysate (CVVHD Ca‐free) group, continuous veno‐venous hemodiafiltration calcium‐free dialysate (CVVHDF Ca‐free) group, and continuous veno‐venous hemodiafiltration Ca‐containing dialysate (CVVHDF Ca‐containing) group at cardiac intensive care unit (CICU). The primary endpoint was the incidence of metabolic complications. The secondary endpoints included premature termination of treatment, thrombus of filter, and bubble trap after the process.
Results
The incidence of citrate accumulation (18.2% vs. 12.1% vs. 21.2%) and metabolic alkalosis (12.1% vs. 0% vs. 9.1%) did not significantly differ among three groups ( p > 0.05 for both). The incidence of premature termination was comparable among the groups (18.2% vs. 9.1% vs. 9.1%, p = 0.582). The thrombus level of the filter and bubble trap was similar in the three groups ( p > 0.05 for all).
Conclusions
In RCA‐CRRT for CICU population, RCA‐CVVHDF with Ca‐containing solutions and traditional RCA with Ca‐free solutions had a comparable safety and feasibility. Trial Registration: ChiCTR2100048238 in the Chinese Clinical Trial Registry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
- Department of Emergency, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
ORCID-Profile: Fanqi Meng
Förderung
- Xiamen Science and Technology Project
- Science and Technology Projects of Fujian Province
- National Natural Science Foundation of China
Zitieren
APA
Huang, S., Sun, G., Wu, P., Wu, L., Jiang, H., Wang, X., Li, L., Gao, L., & Meng, F. (2024). Safety and Feasibility of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy With Calcium‐Containing Solutions: A Randomized Controlled Trial. Seminars in Dialysis. https://doi.org/10.1111/sdi.13200
Vancouver
Huang S, Sun G, Wu P, Wu L, Jiang H, Wang X, et al. Safety and Feasibility of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy With Calcium‐Containing Solutions: A Randomized Controlled Trial. Seminars in Dialysis. 2024. doi:10.1111/sdi.13200
BibTeX
@article{Huang2024,
author = {Huang, Shan and Sun, Guangfeng and Wu, Penglong and Wu, LinJing and Jiang, Hongfei and Wang, Xixing and Li, Liyuan and Gao, Lingling and Meng, Fanqi},
title = {Safety and Feasibility of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy With Calcium‐Containing Solutions: A Randomized Controlled Trial},
journal = {Seminars in Dialysis},
year = {2024},
doi = {10.1111/sdi.13200}
}
EUVIMED